Trials / Completed
CompletedNCT02963389
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim in Pediatric Solid Tumor/Lymphoma Patients
A Phase I Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim After Single Administration in Pediatric Solid Tumor/Lymphoma Patients
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- Dong-A ST Co., Ltd. · Industry
- Sex
- All
- Age
- 6 Years – 19 Years
- Healthy volunteers
- Not accepted
Summary
This is an open-label, single ascending dose study to evaluate safety, tolerability, and pharmacokinetics/pharmacodynamics of Tripegfilgrastim in pediatric solid tumor/lymphoma patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tripegfilgrastim |
Timeline
- Start date
- 2016-10-04
- Primary completion
- 2018-11-01
- Completion
- 2018-11-01
- First posted
- 2016-11-15
- Last updated
- 2019-01-15
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02963389. Inclusion in this directory is not an endorsement.